Xenetic Biosciences (XBIO) Amortizatization of Intangibles (2015 - 2019)
Xenetic Biosciences' (XBIO) quarterly Amortizatization of Intangibles came in at $6450.0 in Q3 2019, down 74.59% on a QoQ basis from $25381.0 in Q4 2016.
Xenetic Biosciences (XBIO) Amortizatization of Intangibles (2015 - 2019) Analysis & Trends
Xenetic Biosciences (XBIO) has 3 years of Amortizatization of Intangibles data on file, last reported at $6450.0 in Q3 2019.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to $6450.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $6450.0 (changed N/A YoY) and the FY2016 annual result came in at $544480.0, up 401.7% from the prior year.
- Amortizatization of Intangibles slipped to $6450.0 in Q3 2019, from $25381.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $315096.0 in Q3 2016 to a low of $6450.0 in Q3 2019.
- A 3-year average of $94208.1 and a median of $57796.0 in 2015 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 521.11% in 2016, down 56.09% in 2016.
- Tracing XBIO's Amortizatization of Intangibles over 3 years: stood at $57796.0 in 2015, then tumbled by 56.09% to $25381.0 in 2016, then slumped by 74.59% to $6450.0 in 2019.
- The last three Amortizatization of Intangibles figures came in at $6450.0 (Q3 2019), $25381.0 (Q4 2016), and $315096.0 (Q3 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 6,450.00 |
| Sep 30, 2019 | 6,450.00 |
| Dec 31, 2016 | 25,381.00 |
| Dec 31, 2016 | 25,381.00 |
| Sep 30, 2016 | 315,096.00 |
| Sep 30, 2016 | 315,096.00 |
| Jun 30, 2016 | 64,157.00 |
| Jun 30, 2016 | 64,157.00 |
| Mar 31, 2016 | 139,846.00 |
| Mar 31, 2016 | 139,846.00 |
| Dec 31, 2015 | 57,796.00 |
| Dec 31, 2015 | 57,796.00 |
| Sep 30, 2015 | 50,731.00 |
| Sep 30, 2015 | 50,731.00 |